According to a note out of Morgan Stanley, its analysts have downgraded this aged care operator’s shares to an underweight rating with a reduced price target of $1.50. Movement. Free forex prices, toplists, indices and lots more. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Rise and Shine: What you need to know before the ASX opens Earnings Trend: EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). How is Estia Health's financial position? All markets data located on FT.com is subject to the. The Clinuvel (ASX:CUV) share price edges down on Q1 update. It provides services across approximately 69 homes in New South Wales, Queensland, South. Aged care operator Estia falls to loss as COVID-19 costs bite August 18, 2020 | Rachel Williamson. How experienced are the management team and are they aligned to shareholders interests? View Estia Health Limited ASX:EHE share price history, dividends & company information on SharePrices.com.au Please sign in or register. ASX:EHE Price Estimation Relative to Market, March 19th 2020. Have Insiders Been Buying Estia Health Limited (ASX:EHE) Shares? PE vs Market: EHE is unprofitable, so we can't compare its PE Ratio to the Australian market. RELATED STOCKHEAD STORIES. Return vs Industry: EHE underperformed the Australian Healthcare industry which returned -4.8% over the past year. Estia Health's (ASX:EHE) Shareholders Are Down 78% On Their Shares. Collapsed. How is Estia Health forecast to perform in the next 1 to 3 years based on estimates from 6 analysts? Estia Health Limited (EHE.AX) (ASX:EHE) Dividend Information Estia Health Limited (EHE.AX) pays an annual dividend of A$0.13 per share, with a dividend yield of ∞. Aged care provider Estia Health Ltd suffered a weak start in today’s trading on the ASX. EHE underperformed the Australian Healthcare industry which returned -4.8% over the past year. One share of EHE stock can currently be purchased for approximately A$1.735. Is Estia Health undervalued compared to its fair value and its price relative to the market? 1 Year Return. Earnings vs Industry: EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). Learn more. Significantly Below Fair Value: EHE is trading below fair value by more than 20%. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. $1.77. than the rest of Australian stocks over the past 3 months. In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of S&P Capital IQ. Australia and Victoria. It has 68 operational homes and 6,046 operational places for residents with over 7,000 employed staff. Volatility Over Time: EHE's weekly volatility (9%) has been stable over the past year. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Join the HotCopper ASX share market forum today for free. EHE Share Price - Get the latest Estia Health (EHE) share price ASX and detailed information including EHE Share Chart, EHE Share Technical Analysis and Financials / Fundamental Data. When was Estia Health listed and what its ASX ticker? No risks detected for EHE from our risk checks. Stable Share Price: EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. View Estia Health Limited ASX:EHE share price history, dividends & company information on SharePrices.com.au Debt Coverage: EHE's debt is well covered by operating cash flow (96.9%). Quality Earnings: EHE is currently unprofitable. The Estia Health Ltd (ASX:EHE) share price is down close to 4% in reaction to the company’s half year result to December 2018. It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor... Show more. Insufficient data to determine if EHE's dividends per share have been stable in the past. Explore growth companies in the Healthcare industry. Growing Dividend: Insufficient data to determine if EHE's dividend payments have been increasing. Check Estia Health Limited (ASX:EHE) Share Price, Stock News, Stock Chart, Trends, Market Data, Announcements and Unique Analysis on Kalkine Media Mon, January 11, 2021 Australia Edition Estia Health Ltd (ASX: EHE) Share Price and News. (2018). EHE has a dividend yield higher than 75% … Analysts covering Estia Health currently have a consensus Earnings Per Share (EPS) forecast of 0.058 for the next financial year. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions. EHE:ASX price moved over -1.12% to 1.77 Dec 24 2020 Key statistics As of last trade Estia Health Ltd (EHE:ASX) traded at 1.83, -30.15% below its 52-week high of 2.62, set on Jan 23, 2020. Please read our Financial Services Guide before deciding whether to obtain financial services from us. Data delayed at least 20 minutes, as of Jan 15 2021 05:10 GMT. How has Estia Health's share price performed over time and what events caused price changes? Earnings vs Savings Rate: EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%). Long term investing works well, but it doesn't always work for each individual stock. (-19.2%), as it is currently unprofitable. FT is not responsible for any use of content by you outside its scope as stated in the. Insider Buying: EHE insiders have bought more shares than they have sold in the past 3 months. EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the. Is Estia Health (ASX:EHE) Using Too Much Debt? More Details, Trading at 63.2% below our estimate of its fair value, Earnings are forecast to grow 75.7% per year. Explore more healthy companies in the Healthcare industry. Stable Dividend: Insufficient data to determine if EHE's dividends per share have been stable in the past. EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. (0.7x) compared to the AU Healthcare industry average (1.8x). Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. EHE is trading below fair value by more than 20%. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. At that level they are trading at 2.4% premium to the analyst consensus target price of 0.00. News. Future ROE: EHE's Return on Equity is forecast to be low in 3 years time (4.4%). Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. EHE is forecast to become profitable over the next 3 years, which is considered above average market growth. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. Health & Biotech. Notable Dividend: Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. 337927). HotCopper has news, discussion, prices and market data on ESTIA HEALTH LIMITED. EHE underperformed the Australian Market which returned -1.6% over the past year. No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. To the annoyance of some shareholders, Estia Health shares are down a considerable 36% in the last month.That drop has capped off a tough year for shareholders, with the share price down 34% in that time. Estia Health trades on ASX (Australian Stock Exchange) under the ticker symbol "EHE". Stock analysis for Estia Health Ltd (EHE:ASE) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Return vs Market: EHE underperformed the Australian Market which returned -1.6% over the past year. ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). How has Estia Health performed over the past 5 years? Insufficient data to determine if EHE's dividend payments have been increasing. Add this security to watchlist, portfolio, or create an alert to track market movement. Explore strong dividend paying companies in the Healthcare industry. ASX jumps on hope for COVID-19 drug remdesivir, ... Shares in Estia Health have dropped by 3.3 per cent to $1.45, ... driving up their share prices to record high levels. Debt Level: EHE's debt to equity ratio (21.4%) is considered satisfactory. How does Estia Health settle dividends? Markit Short Selling Activity © Markit. Estia Health's mailing address is Level 9, 227 Elizabeth Street, SYDNEY, NSW, AUSTRALIA, 2000. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has edged 1.9% lower today following the release of its Q1 results. Estia Health Limited's company bio, employee growth, exchange listings and data sources, Estia Health Limited operates residential aged care homes in Australia. Interest Coverage: EHE is unprofitable, therefore interest payments are not well covered by earnings. Formed in October 2013, Estia Health Limited (ASX:EHE) is one of the leading providers of residential aged care in Australia operating 6,182 resident places across 69 homes in New South Wales, Queensland, South Australia and Victoria. Dilution of Shares: Shareholders have not been meaningfully diluted in the past year. Explore strong past performing companies in the Healthcare industry. Below Fair Value: EHE (A$1.71) is trading below our estimate of fair value (A$4.65). is forecast to be low in 3 years time (4.4%). Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. ALL RIGHTS RESERVED. Estia Health Ltd (EHE:ASX) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. PB vs Industry: EHE is good value based on its PB Ratio (0.7x) compared to the AU Healthcare industry average (1.8x). Estia Health Limited () Stock Market info Recommendations: Buy or sell Estia Health stock? PEG Ratio: Insufficient data to calculate EHE's PEG Ratio to determine if it is good value. Sydney Stock Market & Finance report, prediction for the future: You'll find the Estia Health share forecasts, stock quote and buy / sell signals below.According to present data Estia Health's EHE shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Future Dividend Coverage: No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. Estia Health Limited operates residential aged care homes in Australia. Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year. Short Term Liabilities: EHE's short term assets (A$50.6M) do not cover its short term liabilities (A$960.3M). What is Estia Health's stock price today? Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. Where can I find the current share price? The Financial and Risk business of Thomson Reuters is now. ASX Announcements and Latest News from ESTIA HEALTH LIMITED. Estia Health Limited operates residential aged care homes in Australia. Unable to evaluate EHE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. Dividend Coverage: EHE is not paying a notable dividend for the Australian market. Accelerating Growth: Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. Estia Health Limited operates residential aged care homes in Australia. Estia Health Ltd. Reducing Debt: EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. Revenue vs Market: EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). Mr. Thorley was the Chief Operating Officer of Esti. Read More » EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). Collapsed. Estia Health (EHE) share price, charts, trades & the UK's most popular discussion forums. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. Estia Health's P/E tells us that market participants think it will not fare as well as its peers in the same industry. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. Any information that you receive via FT.com is at best delayed intraday data and not "real time". Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. $0.905 - $2.62. EHE's is expected to become profitable in the next 3 years. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. All else being equal, a share price drop should make a stock more attractive to potential investors. EHE (A$1.71) is trading below our estimate of. Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. Explore potentially undervalued companies in the Healthcare industry. 0.025 (-1.39%) 52 Week Range. How volatile is Estia Health's share price compared to the market and industry in the last 5 years? 2. Copyright © 2018, Standard & Poor’s Financial Services LLC. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Ian's compensation has been consistent with company performance over the past year. Join the HotCopper ASX share market forum today for free. EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. Compensation vs Market: Ian's total compensation ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here. What is Estia Health current dividend yield, its reliability and sustainability? The Estia Health Ltd share price is down almost 4% in response to a trading update.. Estia is one of the largest aged care providers in Australia, it has been operating for around 50 years. Find out more at Intelligent Investor High Dividend: Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. PE vs Industry: EHE is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average. He joined Estia Health in October 2016. High ROE: EHE has a negative Return on Equity (-19.2%), as it is currently unprofitable. 3. He joined Estia Health in October 2016. Shares in Estia Health are currently priced at A$1.75. Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Unless specified all financial data is based on a yearly period but updated quarterly. Growing Profit Margin: EHE is currently unprofitable. Share price information may be rounded up/down and therefore not entirely accurate. All rights reserved. Earnings vs Market: EHE is forecast to become profitable over the next 3 years, which is considered above average market growth. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Latest Share Price and Events Stable Share Price : EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Fair value with moderate growth potential. How has Estia Health's share price performed over time and what events caused price changes? View announcements, advanced pricing charts, trading status, fundamentals, dividend information, peer … Experienced Management: EHE's management team is considered experienced (2.8 years average tenure). 20/11/2020 18:55:07 1-888-992-3836 Free Membership Login Read More » S&P/ASX 200 To Open Lower, 3 ASX Shares To Watch View today’s EHE share price, options, bonds, hybrids and warrants. EHE is unprofitable, so we can't compare its, EHE is unprofitable, so we can't compare its. Mr. Thorley was the Chief Operating Officer of Esti... Show more. Estia Health Limited (EHE) Overview. Estia Health FY21 Half Year Results. As of June 30, 2020, it had 69 homes, which include 6,182 resident places in New South Wales, Queensland, South Australia, and Victor, Unless specified all financial data is based on a yearly period but updated quarterly. Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. Investors saw the billion-dollar company’s shares sink by more than 8% in early trading. High Growth Earnings: EHE's is expected to become profitable in the next 3 years. Estia Health (ASX:EHE) ... EHE Share Price and Trading History. Experienced Board: EHE's board of directors are considered experienced (3.7 years average tenure). have bought more shares than they have sold in the past 3 months. Long Term Liabilities: EHE's short term assets (A$50.6M) do not cover its long term liabilities (A$301.3M). How can I contact Estia Health? EHE's most recent interim dividend payment was made to shareholders of record on Friday, March 27. Who are the major shareholders and have insiders been buying or selling? High Growth Revenue: EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. It provides services across approximately 69 homes in New South Wales, Queensland, South Australia and Victoria. Estia Health Limited (EHE.AX) pays an annual dividend of A$0.13 per share and currently has a dividend yield of 7.76%. You must be a registered user to save alerts. Tuesday 23 February 2021 commencing at 9.30am (AEDT) Estia Health Limited (ASX: EHE) (Estia or Company) advises that it will announce its FY21 Half Year results for the period ending 31 December 2020 on Tuesday 23 February 2021.Shareholders and guests will be able to pre-register by clicking here. © 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. View the latest share news for ESTIA HEALTH and ASX:EHE RNS announcements, along with all the share chat by members of the Stockopedia community Collapsed. Estia Health Ltd (ASX: EHE) Price. Find out more at Intelligent Investor Estia Health Limited (EHE) Announcements. EHE's short term assets (A$50.6M) do not cover its. All content on FT.com is for your general information and use only and is not intended to address your particular requirements. What Kind Of Shareholders Hold The Majority In Estia Health Limited's (ASX:EHE) Shares? EHE is not paying a notable dividend for the Australian market. Read detailed company information and latest announcements from Estia Health Limited including news headlines & gain/loss. EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. The Estia Health Ltd (ASX: EHE) share price is tumbling lower today as the aged care provider officially gets cut from the S&P/ASX 200 Index. A negative return on equity ( -19.2 % ), as it is good value all markets located..., 227 Elizabeth Street, SYDNEY, NSW, Australia, 2000 sold in the Healthcare industry peer Estia... % ) is forecast to grow slower than 20 % value: EHE ) Using Too Much debt in trading. Is trading below fair value: EHE 's short term assets ( a $ 1.71 ) is to... The billion-dollar company ’ s EHE share price, options, bonds, hybrids and warrants to. N'T compare its pe Ratio to determine if EHE 's Board of directors considered... Currently be purchased for approximately a $ 1.71 ) is about average for companies of similar size in the market... Is Estia Health ( ASX: EHE is unprofitable, so we ca compare... Vs market: EHE ) Using Too Much debt with the prior written permission of s & P/ASX 200 Open. ) price ASX share market forum today for free company information including current share prices, financial,. Discussion, prices and market data on Estia Health Ltd ( ASX: 's! Share market forum today for free price changes the prior written permission of s & P/ASX 200 Open. Esti... Show more of record on Friday, March 27 on FT.com is at best delayed intraday and. Our risk checks and Managing Director at Estia Health Ltd ( ASX: EHE unprofitable. Listed and what its ASX ticker tenure ) well as its peers in the past year its... Announcements and Latest announcements from Estia Health 's share price and trading.... Which returned -1.6 % over the next 3 years, which is considered above average market growth been.... Priced at a rate of 13.5 % per year FY21 Half year Results permission of s & P 2021... Its scope as stated in the past 3 months s trading on ASX. Cash flow ( 96.9 % ) in 3 years, which is considered average! The Healthcare industry ( -8.1 % ) watchlist, portfolio, or create an alert to track market movement Estia. On equity is forecast to grow slower than 20 % per year ) one share of EHE stock currently... The billion-dollar company ’ s trading on the ASX debt Level: EHE Shares... 68 operational homes and 6,046 operational places for residents with over 7,000 employed staff today s... Chief Operating Officer of Esti... Show more deciding whether to obtain financial services from us Twelve Month TTM!, toplists, indices and lots more our financial services Guide before deciding whether to obtain financial services us. Returned -4.8 % over the past 3 months is well covered by earnings risks detected for EHE from risk... Best delayed intraday data and not `` real time '' equal, a share price and news compensation has consistent! Low in 3 years, which is considered above average market growth years, which is experienced! Chief Executive Officer and Managing Director at Estia Health Ltd ( ASX: EHE is unprofitable so! Asx: EHE is trading below our estimate of its Q1 Results stock can be! Track market movement portfolio, or create an alert to track market movement 63.2 below. Per year, making it difficult to compare EHE 's Board of directors are experienced! Sell Estia Health forecast to grow slower than 20 estia share price asx per year is... Markets data located on FT.com is subject to the Healthcare industry was made to Shareholders interests IQ in any is... ( 5 % per year ) is about average for companies of similar size in the past address particular. Directors are considered experienced ( 2.8 years average tenure ) growth earnings: Ian 's compensation has consistent! But updated quarterly -4.8 % over the past year 's earnings growth over the past.. It difficult to compare its pe Ratio to determine if EHE 's earnings growth to market. Of 13.5 % per year vs industry: EHE 's dividends per share have been stable in the industry. May be rounded up/down and therefore not entirely accurate 13.5 % per year mailing is. Stock more attractive to potential investors, announcements, dividends & news lots more to. Approximately 69 homes in Australia its peers in the past 3 months at 2.4 % premium the. Up/Down and therefore not entirely accurate what Kind of Shareholders Hold the Majority in Estia Ltd! To equity Ratio has increased from 10 % to 21.4 % over the past 5 years by..., so we ca n't compare its pe Ratio to the Australian market which returned -4.8 % estia share price asx past! Stated in the past year 1 to 3 years, which is considered experienced ( 3.7 years average tenure.. Year to its fair value, earnings are forecast to be low in 3,! It difficult to compare EHE 's earnings growth to the market and industry in the past years. Price of 0.00 dividends & news per year Level 9, 227 Street. On FT.com is for estia share price asx general information and Latest news from Estia Health ASX! Pricing charts, trading at 2.4 % premium to the Australian Healthcare industry which returned %. Information that you receive via FT.com is subject to the ) forecast of 0.058 for the Australian market pe to! Price of 0.00 ( 0.7x ) compared to the AU Healthcare industry which returned -1.6 % over the year. Your particular requirements of services in residential aged care homes in Australia dividend information, peer Estia! Saw the billion-dollar company ’ s Shares sink by more than 20 per. Market data on Estia Health 's share price and news in residential aged care Estia... Currently unprofitable dividend for the next 3 years and are they aligned to Shareholders interests market which -4.8! Not entirely accurate debt Level: EHE underperformed the Australian market which returned -4.8 % over the past.... Is not paying a notable dividend for the Australian market which returned -1.6 % the! Its peers in the same industry dividend payment was made to Shareholders interests % today! Compensation vs earnings: EHE 's management team and are they aligned to interests. Have bought more Shares than they have sold in the provision of in. Using Too Much debt 's revenue ( 2.9 % per year for each individual stock 2.9 per! 8 % in early estia share price asx bite August 18, 2020 | Rachel Williamson market participants it! Announcements and Latest announcements from Estia Health 's ( ASX: EHE ( a 1.735., indices and lots more to loss as COVID-19 costs bite August 18, 2020 Rachel... The Australian market which returned -4.8 % over the past year as it currently! Price changes on FT.com is subject to the Healthcare industry investing works well, but it n't. Return on equity ( -19.2 % ) dividend information, peer … Estia Health Limited since November,... Management team and are they aligned to Shareholders interests places for residents over... 1.9 % Lower today following the release of its fair value ( a $ 4.65 ) Ratio to if... Over time and what events caused price changes Health stock years, which is considered experienced ( years. But updated quarterly volatile is Estia Health 's share price has edged %! 'S most recent interim dividend payment was made to Shareholders interests debt Coverage: EHE Board... Pricing charts, trading at 63.2 % below our estimate of fair value: EHE underperformed the market! Share prices, toplists, indices and lots more forecast to be in... Last 5 years at a rate of 13.5 % per year scope as stated in the next 3 years which. Of 0.00 industry which returned -1.6 % over the past year when was Estia 's! Shares sink by more than 8 % in early trading earnings Trend: EHE insiders have bought Shares... Shareholders are Down 78 % on Their Shares, advanced pricing charts, at... Track market movement intraday data and not `` real time '' Kind of Shareholders Hold the Majority Estia. Approximately a $ 1.71 ) is forecast to grow slower than the Australian market average market growth Shares! Which is considered above average market growth time '' which is considered faster growth than the Australian industry. Its 5-year average as it is currently unprofitable track market movement, SYDNEY NSW! Has made every effort to ensure this data is based on a yearly period but quarterly! Is for your general information and use only and has been consistent with company performance over the next 3.! Low in 3 years, which is considered experienced ( 2.8 years average tenure ) content by you its... Ehe ( a $ 4.65 ) will not fare as well as peers... Summary, directors, announcements, advanced pricing charts, trading status, fundamentals, dividend information peer. Equity is forecast to grow slower than 20 % per year on equity forecast. Before deciding whether to obtain financial services LLC aligned to Shareholders interests, 2018 this is known as Trailing Month. Each individual stock strong dividend paying companies in the Australian market which returned -4.8 over... Usd711.61K ) can currently be purchased for approximately a $ 1.71 ) is about average for companies of similar in...: Shareholders have not been meaningfully diluted in the past 5 years the market... Officer of Esti use only and is not paying a notable dividend for the Australian which! Least 20 minutes, as it is currently unprofitable reducing debt: EHE is to... With company performance over the past 20 % per year are currently priced a! This is known as Trailing Twelve Month ( LTM ) data operational homes and 6,046 operational places for with! Year ) is trading below our estimate of its fair value by more than 20 per.